The Institute for Safe Medication Practices (ISMP) is alerting health care providers about potential confusion over new alternative packaging for casirivimab and imdevimab. These monoclonal antibodies, administered together as REGEN-COV, are used for treating COVID-19. ISMP recently received multiple reports about these types of errors.

Why should you factor location and state regulations into your career decision-making process? Two accomplished pharmacists provide answers and highlight their regions.

When exploring postgraduate opportunities, it is important to research and ask about the scope of practice of that state and institution.

“Paul” was sick with COVID-19 and starting to have trouble breathing. But when he went to the local emergency department (ED) on a Friday evening, they turned him away because they didn’t have any more beds. As a last resort, he went to De Queen Health and Wellness Pharmacy in De Queen, AR, where he heard he could get treatment.

September 9, 2021, was a busy day for the federal government and pharmacy stakeholders alike: Just a few hours apart, we saw significant developments in pharmacists’ COVID-19 pandemic practice authorities and prescription drug pricing. Both items yielded positive news for pharmacists and their patients.